drug
telotristat ethyl
Marketedupdated 3mo agoby TerSera Therapeutics LLC
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying telotristat ethyl
Patent cliff
source: FDA Orange Bookfirst barrier falls
Dec 11, 2027
~1.3 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (5)
- Feb 28, 2031compositionUS 77094934.5y
- Feb 27, 2031compositionUS 81932044.5y
- Dec 19, 2028method-of-use (U-1979)US 86530942.3y
- Dec 11, 2027compositionUS 75538401.3y
- Dec 11, 2027method-of-use (U-1979)US 79685591.3y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 31m ago
Found something off?
comments(0)
5-min edit window · permanent after that